Related Experiment Video
Updated: Oct 29, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
A macrophage attack culminating in microthromboses characterizes COVID 19 pneumonia
1Department of Pathology and Human Anatomy School of Medicine, Loma Linda University, Loma Linda, California, USA.
Introduction:
A neutrophilic infiltrate characterizes bacterial pneumonia. Macrophage infiltration is similarly characteristic of the viral pneumonia caused by SARS-CoV-2. These infiltrating macrophages, while phagocytic and capable of engulfing virus laden alveolar cells, are also rich in tissue factor-a thromboplastin. This prothrombotic aspect likely explains how a respiratory virus whose malign effects should be confined to the oropharynx, bronchi and lungs, can cause a panoply of extra-pulmonary organ disorders. Elevated ferritin levels in ICU Covid 19 patients, and elevated acute phase proteins suggest immune overreaction. Elevated d-dimers implicate clotting as well. This evidence links hyperactive innate immunity (macrophage lung infiltrates) with the elevated levels of oligomeric fibrin present in the bloodstream of these patients.
Methods:
An in-house assay measuring oligomeric (soluble) fibrin (also referred to as soluble fibrin monomer complexes or SFMC) in whole blood, previously developed for monitoring incipient disseminated intravascular coagulation (DIC) during liver transplantation, was made available to COVID ICU attendings. Since SFMC constitutes the input to intravascular fibrin clots and d-dimer reflects fibrin clot dissolution, it was thought that the two tests, run in tandem along with assays of immune activation, might clarify the frequency and possibly the cause of DIC in patients with severe COVID-19 pneumonia.
Results:
Classical DIC with intravascular clotting and thrombocytopenia was documented only rarely. However, early in the pandemic shortly after the assay was made available, it identified three patients undergoing acute defibrination. In each patient virtually all of the body's fibrinogen was transformed into SFMC over 3-4 days and deposited somewhere in the vasculature without any gross clots being detected.
Conclusions:
Three COVID-19 patients with evidence of a hyperactive immune response (elevated ferritin and acute phase proteins) defibrinated while blood levels of SFMC were being monitored. SFMC levels that were five times higher than normal appeared in the circulation during the defibrination process. SFMC at these levels may precipitate as showers of microclots, damaging heart, kidney, brain, and so forth.
Insights
Severe COVID-19 pneumonia can cause defibrination due to high levels of soluble fibrin monomer complexes (SFMC). These elevated SFMC levels may lead to microclot formation, potentially causing widespread organ damage in patients with hyperactive immune responses.
Area of Science:
- Immunology
- Hematology
- Virology
Background:
- Bacterial pneumonia involves neutrophilic infiltration, while SARS-CoV-2 viral pneumonia is characterized by macrophage infiltration.
- Macrophages in SARS-CoV-2 pneumonia are rich in tissue factor, contributing to a prothrombotic state and extra-pulmonary organ damage.
- Elevated ferritin, acute phase proteins, and d-dimers in severe COVID-19 patients suggest immune overreaction and clotting activation.
Purpose of the Study:
- To investigate the role of soluble fibrin monomer complexes (SFMC) in severe COVID-19 pneumonia.
- To correlate SFMC levels with immune activation markers and disseminated intravascular coagulation (DIC) in COVID-19 patients.
- To clarify the frequency and potential causes of DIC in severe COVID-19 pneumonia.
Main Methods:
- Utilized an in-house assay to measure whole blood SFMC levels, a marker for incipient DIC.
- Monitored SFMC levels in tandem with immune activation assays and d-dimer levels.
- Compared SFMC levels with clinical presentation of clotting and defibrination.
Main Results:
- Classical DIC with intravascular clotting and thrombocytopenia was rarely observed.
- Three patients exhibited acute defibrination, with fibrinogen rapidly converting to SFMC and depositing in the vasculature.
- SFMC levels were five times higher than normal during the defibrination process in these patients.
Conclusions:
- Severe COVID-19 patients with hyperactive immune responses can experience defibrination linked to markedly elevated SFMC levels.
- High SFMC levels may precipitate as microclots, leading to damage in multiple organs (heart, kidney, brain).
- SFMC monitoring is crucial for understanding and potentially managing thrombotic complications in severe COVID-19.
Related Concept Videos
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Venous Thrombosis I: Introduction
Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

